Literature DB >> 27357431

Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA).

M Radenkovic1, C Silver1, J Arvastsson1, K Lynch2, Å Lernmark1, R A Harris3, C-D Agardh1, C M Cilio1,4.   

Abstract

Latent autoimmune diabetes of the adults (LADA) accounts for up to 12% of all patients with diabetes. Initially the disease resembles type 2 diabetes (T2D); however, the typical presence of β cell autoantibodies indicates an autoimmune basis of LADA. While dysfunctional regulatory T cells (Tregs ) have been implicated in autoimmune diabetes, these cells have been scarcely studied in LADA. The aim of this study was to investigate the frequency and phenotype of circulating Tregs in LADA patients early during disease progression. Flow cytometric analysis was performed on whole blood and peripheral mononuclear cells (PBMC) from patients diagnosed with LADA prior to insulin deficiency (n = 39) and from healthy volunteers (n = 20). Overall, we found the frequency and activation status of peripheral putative Tregs to be altered in LADA patients compared to healthy controls. While total T cells and CD4(+) T cells expressing high levels of CD25 (CD4(+) CD25(hi) ) were unchanged, the frequency and total numbers of CD4(+) T cells expressing an intermediate level of CD25 (CD4(+) CD25(int) ) were decreased in LADA patients. Interestingly, the expression of the Treg -specific marker forkhead box protein 3 (FoxP3), as well as the activation and memory makers CD69, cytotoxic T lymphocyte associated antigen 4 (CTLA-4), CCR4 and CD45RO were increased in CD4(+) CD25(+) T cells of the patients. Our data depict phenotypical changes in T cells of LADA patients that may reflect a derangement in peripheral immune regulation contributing to the slow process leading to insulin-dependent diabetes in these patients.
© 2016 British Society for Immunology.

Entities:  

Keywords:  autoimmunity; diabetes; regulatory T cells

Mesh:

Substances:

Year:  2016        PMID: 27357431      PMCID: PMC5011368          DOI: 10.1111/cei.12834

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  [Abnormal T cell autoimmunity against GAD65 in LADA patients].

Authors:  Yi Zhang; Zhi-guang Zhou; Lin Yang; Jian Lin; Xia Li; Wei-min He
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2010-07-27

2.  Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species.

Authors:  Frankie B Stentz; Abbas E Kitabchi
Journal:  Biochem Biophys Res Commun       Date:  2005-09-23       Impact factor: 3.575

3.  Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4.

Authors:  M N Pham; M I Hawa; C Pfleger; M Roden; G Schernthaner; P Pozzilli; R Buzzetti; W A Scherbaum; W Scherbaum; J Seissler; H Kolb; S Hunter; R D G Leslie; N C Schloot
Journal:  Diabetologia       Date:  2011-02-24       Impact factor: 10.122

4.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  CD69: an unexpected regulator of TH17 cell-driven inflammatory responses.

Authors:  Pilar Martín; Francisco Sánchez-Madrid
Journal:  Sci Signal       Date:  2011-03-22       Impact factor: 8.192

6.  The World Health Organization International Collaborative Study for islet cell antibodies.

Authors:  A R Mire-Sluis; R Gaines Das; A Lernmark
Journal:  Diabetologia       Date:  2000-10       Impact factor: 10.122

7.  Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.

Authors:  Jun Wang; Andreea Ioan-Facsinay; Ellen I H van der Voort; Tom W J Huizinga; René E M Toes
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

8.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 9.  CTLA-4: new insights into its biological function and use in tumor immunotherapy.

Authors:  Jackson G Egen; Michael S Kuhns; James P Allison
Journal:  Nat Immunol       Date:  2002-07       Impact factor: 25.606

Review 10.  Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society.

Authors:  R Mallone; S I Mannering; B M Brooks-Worrell; I Durinovic-Belló; C M Cilio; F S Wong; N C Schloot
Journal:  Clin Exp Immunol       Date:  2010-10-05       Impact factor: 4.330

View more
  12 in total

Review 1.  Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.

Authors:  Xia Wang; Peilin Zheng; Gan Huang; Lin Yang; Zhiguang Zhou
Journal:  Clin Exp Med       Date:  2018-07-17       Impact factor: 3.984

Review 2.  Structure and function of the exocrine pancreas in patients with type 1 diabetes.

Authors:  Laure Alexandre-Heymann; Roberto Mallone; Christian Boitard; Raphaël Scharfmann; Etienne Larger
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

Review 3.  Adult-onset autoimmune diabetes.

Authors:  Raffaella Buzzetti; Ernesto Maddaloni; Jason Gaglia; R David Leslie; F Susan Wong; Bernhard O Boehm
Journal:  Nat Rev Dis Primers       Date:  2022-09-22       Impact factor: 65.038

4.  microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus.

Authors:  Shan Pan; Mengyu Li; Haibo Yu; Zhiguo Xie; Xia Li; Xianlan Duan; Gan Huang; Zhiguang Zhou
Journal:  Acta Diabetol       Date:  2020-08-20       Impact factor: 4.280

5.  Glibenclamide Prevents Diabetes in NOD Mice.

Authors:  Smaragda Lamprianou; Conny Gysemans; Joanna Bou Saab; Helena Pontes; Chantal Mathieu; Paolo Meda
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

6.  Reduced Histone H3 Lysine 9 Methylation Contributes to the Pathogenesis of Latent Autoimmune Diabetes in Adults via Regulation of SUV39H2 and KDM4C.

Authors:  Xi-Yu Liu; Hong Li
Journal:  J Diabetes Res       Date:  2017-03-15       Impact factor: 4.011

7.  Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes.

Authors:  K Singh; M Martinell; Z Luo; D Espes; J Stålhammar; S Sandler; P-O Carlsson
Journal:  Clin Exp Immunol       Date:  2019-03-24       Impact factor: 4.330

Review 8.  Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy.

Authors:  Jingyi Hu; Rong Zhang; Hailan Zou; Lingxiang Xie; Zhiguang Zhou; Yang Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-21       Impact factor: 6.055

9.  First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes.

Authors:  Diana L Cousminer; Emma Ahlqvist; Rajashree Mishra; Mette K Andersen; Alessandra Chesi; Mohammad I Hawa; Asa Davis; Kenyaita M Hodge; Jonathan P Bradfield; Kaixin Zhou; Vanessa C Guy; Mikael Åkerlund; Mette Wod; Lars G Fritsche; Henrik Vestergaard; James Snyder; Kurt Højlund; Allan Linneberg; Annemari Käräjämäki; Ivan Brandslund; Cecilia E Kim; Daniel Witte; Elin Pettersen Sørgjerd; David J Brillon; Oluf Pedersen; Henning Beck-Nielsen; Niels Grarup; Richard E Pratley; Michael R Rickels; Adrian Vella; Fernando Ovalle; Olle Melander; Ronald I Harris; Stephen Varvel; Valdemar E R Grill; Hakon Hakonarson; Philippe Froguel; John T Lonsdale; Didac Mauricio; Nanette C Schloot; Kamlesh Khunti; Carla J Greenbaum; Bjørn Olav Åsvold; Knud B Yderstræde; Ewan R Pearson; Stanley Schwartz; Benjamin F Voight; Torben Hansen; Tiinamaija Tuomi; Bernhard O Boehm; Leif Groop; R David Leslie; Struan F A Grant
Journal:  Diabetes Care       Date:  2018-09-25       Impact factor: 19.112

10.  Transcriptome profiling of microRNAs associated with latent autoimmune diabetes in adults (LADA).

Authors:  Ke Yu; Zhou Huang; Jing Zhou; Jianan Lang; Yan Wang; Xingqi Yin; Yuan Zhou; Dong Zhao
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.